Biotech-CEO: This is a huge marketing scoop for us
The CEO of a Danish biotech company has struck a deal with two major organizations focusing on cancer immunotherapy, the US Cancer Immunotherapy Consortium (CIC) of the Cancer Research Institute and the European Association for Cancer Immunotherapy (CIMT).
by Henrik Tüchsen
Biotech and diagnostics company Immudex, which was named ‘Entrepreneur of the Year’ within life science in 2011, has just signed a new deal that could prove crucial to the company. It is recognition of the company and a huge scoop, says CEO, Henrik Pedersen.
Allerede abonnent?Log ind her
Læs hele artiklen
Få adgang i 14 dage for 0 kr. Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.
Med din prøveperiode får du:
- Adgang til alle låste artikler
- Modtag vores daglige nyhedsbreve
- Fuld adgang til vores app
Få fuld adgang til dig og dine kollegaer
Start et gratis virksomhedsprøveabonnementRelaterede artikler:
Biotech award-winner in search of new capital
For abonnenter
.jpg&w=384&q=75)
